{
    "nctId": "NCT00599924",
    "officialTitle": "Phase I Study Of SU011248 In Combination With Oxaliplatin, Leucovorin, And 5-Fluorouracil In Patients With Advanced Solid Malignancies",
    "inclusionCriteria": "* Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients wtih adenocarcinoma of the colon or rectum)\n* Eastern Cooperative Oncology Group (ECOG) 0 or 1\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens\n* Prior treatment with more than 2 cycles of carboplating-based chemotherapy regimens\n* For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting"
}